Bifidobacterium bifidum can stimulate interleukin-12 (IL-12) production followed by enhanced recruitment of tumor-specific cytotoxic T lymphocytes (CTLs) and concomitant release of interferon-gamma (IFN-γ) [86, 87]. The gene discussed is IFNG; the disease is neoplasm.